Document is current
Any future updates will be listed below
-
Authors
Hammad, Noureddine
Ransy, Céline
Pinson, Benoit
Talmasson, Jeremy
Bréchot, Christian
Rossignol, Jean-François
Bouillaud, Frédéric
-
Funding
Funding for this research was provided by:
Romark Global Pharma, LLC (181321A11)
- License Information
-
More Information
Article History
Received: 30 January 2024
Accepted: 4 November 2024
First Online: 28 December 2024
Competing interests
: The study was undertaken on demand by Romark (CB & JFR). This demand was motivated by known expertise of the team and furthermore matched with its scientific interests. Accordingly, Romark provided a research grant to FB that covered NH salary (24 months) and experimental expenses. JFR is Chief Medical and Science Officer of Romark. CB is executive director of the Romark institute for the Study of Liver diseases. . Other authors declared no competing interest.
